UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Nature communications, 2018-03, Vol.9 (1), p.896-10, Article 896

2018

Link zum Volltext

Verfügbarkeit prüfen

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

Journal of clinical oncology, 2012-05, Vol.30 (15), p.1879-1887

2012

Link zum Volltext

Verfügbarkeit prüfen

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

The lancet oncology, 2013-09, Vol.14 (10), p.989-998

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

The lancet oncology, 2010-03, Vol.11 (3), p.231-240

2010

Link zum Volltext

Verfügbarkeit prüfen

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Nature communications, 2023-07, Vol.14 (1), p.4017-4017, Article 4017

2023

Link zum Volltext

Verfügbarkeit prüfen

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The lancet oncology, 2017-07, Vol.18 (7), p.929-945

2017

Link zum Volltext

Verfügbarkeit prüfen

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

The lancet oncology, 2007-02, Vol.8 (2), p.119-127

2007

Link zum Volltext

Verfügbarkeit prüfen

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Health technology assessment (Winchester, England), 2023-11, Vol.27 (25), p.1-176

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Breast cancer research : BCR, 2023-04, Vol.25 (1), p.39-39, Article 39

2023

Link zum Volltext

Verfügbarkeit prüfen

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study

Breast cancer research : BCR, 2022-09, Vol.24 (1), p.61-61, Article 61

2022

Link zum Volltext

Verfügbarkeit prüfen

Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer

Trials, 2022-05, Vol.23 (1), p.372-372, Article 372

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients

Breast cancer research : BCR, 2019-12, Vol.22 (1), p.2-20, Article 2

2019

Link zum Volltext

Verfügbarkeit prüfen

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Link zum Volltext

Verfügbarkeit prüfen

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design

Trials, 2021-06, Vol.22 (1), p.397-397, Article 397

2021

Link zum Volltext

Verfügbarkeit prüfen

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

Breast cancer research : BCR, 2012-03, Vol.14 (2), p.R46-R46, Article R46

2012

Link zum Volltext

Verfügbarkeit prüfen

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

The Lancet (British edition), 2017-09, Vol.390 (10099), p.1048-1060

2017

Link zum Volltext

Verfügbarkeit prüfen

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

NPJ breast cancer, 2021-02, Vol.7 (1), p.11-11, Article 11

2021

Link zum Volltext

Verfügbarkeit prüfen

Conducting non-commercial international clinical trials: the ICR-CTSU experience

Trials, 2017-09, Vol.18 (1), p.440-4, Article 440

2017

Link zum Volltext

Verfügbarkeit prüfen

In Regard to Vaidya et al

International journal of radiation oncology, biology, physics, 2015-08, Vol.92 (5), p.954-955

2015

Link zum Volltext

Verfügbarkeit prüfen

Implementation of platform trials in the COVID-19 pandemic: A rapid review

Contemporary clinical trials, 2022-01, Vol.112, p.106625-106625, Article 106625

2022

Link zum Volltext

Verfügbarkeit prüfen

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-05, Vol.327 (20), p.1963

2022

Link zum Volltext

Verfügbarkeit prüfen

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply

The Lancet (British edition), 2024-05, Vol.403 (10438), p.1752-1752

2024

Link zum Volltext

Verfügbarkeit prüfen

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Radiotherapy and oncology, 2016-07, Vol.120 (1), p.114-118

2016

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Journal of clinical oncology, 2022-01, Vol.40 (3), p.282-293

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 139

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(135)
Mit Volltextzugriff
(125)

Publikationsform

Artikel
(139)

Sprache

Englisch
(139)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer

Dissecting the Heterogeneity of Triple-Negative Breast Cancer

Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor-positive locally advanced or metastatic breast cancer (SoFEA): a composite, multicentre, phase 3 randomised trial

Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study

One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Relationship between ER expression by IHC or mRNA with Ki67 response to aromatase inhibition: a POETIC study

Operational complexity versus design efficiency: challenges of implementing a phase IIa multiple parallel cohort targeted treatment platform trial in advanced breast cancer

Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

Impact of aromatase inhibitor treatment on global gene expression and its association with antiproliferative response in ER+ breast cancer in postmenopausal patients

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Can patient decision aids reduce decisional conflict in a de-escalation of breast radiotherapy clinical trial? The PRIMETIME Study Within a Trial implemented using a cluster stepped-wedge trial design

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial

Meta-analyses of visceral versus non-visceral metastatic hormone receptor-positive breast cancer treated by endocrine monotherapies

Conducting non-commercial international clinical trials: the ICR-CTSU experience

In Regard to Vaidya et al

Implementation of platform trials in the COVID-19 pandemic: A rapid review

Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial

Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial – Authors' reply

Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial

Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

Aktive Filter

Suchergebnisse filtern